Sacubitril is a/an
## **Core Concept**
Sacubitril is a drug used in the treatment of heart failure. It belongs to a class of medications known as neprilysin inhibitors. Neprilysin is an enzyme that breaks down various peptides, including natriuretic peptides, which are beneficial in heart failure.
## **Why the Correct Answer is Right**
Sacubitril works by inhibiting neprilysin, an enzyme responsible for the breakdown of natriuretic peptides. By preventing the breakdown of these peptides, sacubitril increases their levels, leading to vasodilation, natriuresis, and diuresis, which are beneficial effects in heart failure patients. It is often used in combination with valsartan (an angiotensin II receptor blocker) for the treatment of heart failure, known as sacubitril/valsartan.
## **Why Each Wrong Option is Incorrect**
- **Option A:** This option is incorrect because sacubitril does not primarily function as an angiotensin-converting enzyme (ACE) inhibitor. ACE inhibitors work by blocking the conversion of angiotensin I to angiotensin II, a potent vasoconstrictor.
- **Option B:** This option is incorrect because sacubitril is not a beta-blocker. Beta-blockers reduce the workload on the heart and reduce its oxygen demand by blocking the effects of the hormone epinephrine.
- **Option C:** This option might seem plausible because sacubitril can be part of a combination therapy that includes valsartan, which is an angiotensin II receptor blocker (ARB). However, sacubitril itself is specifically a neprilysin inhibitor.
- **Option D (Correct Answer):** Neprilysin inhibitor. This is correct because sacubitril specifically works by inhibiting the neprilysin enzyme.
## **Clinical Pearl / High-Yield Fact**
A key clinical pearl is that sacubitril/valsartan has been shown to reduce mortality and morbidity in patients with heart failure with reduced ejection fraction (HFrEF) compared to ACE inhibitors. It's essential to remember that sacubitril should not be administered within 36 hours of an ACE inhibitor due to the increased risk of angioedema.
## **Correct Answer:** D. Neprilysin inhibitor.